Skip to content

EVALUATION AND COMPARISON OF SAFETY AND EFFICACY OF TWO ANTI-ACNE TEST PRODUCTS ON MILD TO MODERATE ACNE.

EVALUATION AND COMPARISON OF SAFETY AND EFFICACY OF TWO ANTI-ACNE TEST PRODUCTS ON MILD TO MODERATE ACNE.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2011/04/001662
Enrollment
36
Registered
2011-04-04
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Plaster cushion roll Patch) -OP-Z: Apply 1 patch per lesion as per randomization code. Intervention2: Plaster cushion roll (Patch)-OP-S : Apply 1 patch per lesion as per randomization c

Sponsors

OPLON
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Voluntary men/women with 4 acne lesions with nearly the same severity score and similar maturation age (per history) on the entire face. 2. Age between 18 â?? 25 years. 3. No treatment for acne in the past 1 month 4. Phototype III and IV. 5. All skin types (greasy, normal) except known significant sensitive skin. 6. Accepting not to use products with the same end benefit during the entire study duration. 7. For whom the Investigator considers that the compliance will be correct. 8. Cooperating, informed of the need and duration of the examinations, and ready to comply with protocol procedures. 9. Having signed a Consent Form and will be once informed orally and in writing of all information concerning the study procedures and study objectives.

Exclusion criteria

Exclusion criteria: 1. Pregnant women and lactating women. In any case of suspicion a pregnancy test shall be preformed. 2. History suggestive of any hormonal problems. 3. History of allergic dermatitis or contact allergy to cosmetics, 4. Subjects on oral retinoid since the past 3 months. 5. Hypersensitivity to any cosmetic product, raw material. 6. Any clinically significant systemic or cutaneous disease, which may interfere with study treatments or procedures. 7. Subjects on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month). 8. Subject in an exclusion period or participating in another similar cosmetic or therapeutic trial.

Design outcomes

Primary

MeasureTime frame
1. Dermatological Grading of acne lesions.Timepoint: The study will be conducted over a period of 40 hours and would involve 3 visits- [Visit 1 (0 hour), Visit 2 (16 Hours) and Visit 3(40 Hours)].

Secondary

MeasureTime frame
1. Dermatological evaluation of cutaneous tolerance at all visits.Timepoint: 1. 0 hour, 16 Hours and 40 Hours.

Countries

India

Contacts

Public ContactDr Rajiv Joshi
rsjdr@rediffmail.com66758851

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026